These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2674864)
21. The precursor to major merozoite surface antigens: structure and role in immunity. Holder AA Prog Allergy; 1988; 41():72-97. PubMed ID: 3043424 [No Abstract] [Full Text] [Related]
22. The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens. Satterthwait AC; Arrhenius T; Hagopian RA; Zavala F; Nussenzweig V; Lerner RA Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):565-72. PubMed ID: 2569211 [TBL] [Abstract][Full Text] [Related]
23. Specific and nonspecific immunodiagnostic properties of recombinant and synthetic Plasmodium falciparum antigens. Knobloch J; Schreiber M; Grokhovsky S; Scherf A Eur J Clin Microbiol; 1987 Oct; 6(5):547-51. PubMed ID: 3325284 [TBL] [Abstract][Full Text] [Related]
24. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Malkin EM; Diemert DJ; McArthur JH; Perreault JR; Miles AP; Giersing BK; Mullen GE; Orcutt A; Muratova O; Awkal M; Zhou H; Wang J; Stowers A; Long CA; Mahanty S; Miller LH; Saul A; Durbin AP Infect Immun; 2005 Jun; 73(6):3677-85. PubMed ID: 15908397 [TBL] [Abstract][Full Text] [Related]
26. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. Barr PJ; Green KM; Gibson HL; Bathurst IC; Quakyi IA; Kaslow DC J Exp Med; 1991 Nov; 174(5):1203-8. PubMed ID: 1940798 [TBL] [Abstract][Full Text] [Related]
27. Vaccines for human malaria: epidemiological and immunological perspectives. Webster HK; Diggs CL; Ballou WR; Chulay JD Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321 [No Abstract] [Full Text] [Related]
28. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum. Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382 [TBL] [Abstract][Full Text] [Related]
29. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Healer J; McGuinness D; Carter R; Riley E Parasitology; 1999 Nov; 119 ( Pt 5)():425-33. PubMed ID: 10599074 [TBL] [Abstract][Full Text] [Related]
30. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA. Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G Malar J; 2016 Mar; 15():161. PubMed ID: 26979066 [TBL] [Abstract][Full Text] [Related]
31. Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite. von Brunn A; Früh K; Müller HM; Zentgraf HW; Bujard H Vaccine; 1991 Jul; 9(7):477-84. PubMed ID: 1716808 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
34. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. Carter R; Graves PM; Quakyi IA; Good MF J Exp Med; 1989 Jan; 169(1):135-47. PubMed ID: 2642527 [TBL] [Abstract][Full Text] [Related]
35. Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum. Udomsangpetch R; Lundgren K; Berzins K; Wåhlin B; Perlmann H; Troye-Blomberg M; Carlsson J; Wahlgren M; Perlmann P; Björkman A Science; 1986 Jan; 231(4733):57-9. PubMed ID: 3510452 [TBL] [Abstract][Full Text] [Related]
36. A recombinant hybrid protein as antigen for an anti-blood stage malaria vaccine. Knapp B; Hundt E; Enders B; Küpper HA Behring Inst Mitt; 1991 Feb; (88):147-56. PubMed ID: 2049032 [TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review. Heidrich HG Z Parasitenkd; 1986; 72(1):1-11. PubMed ID: 3515789 [No Abstract] [Full Text] [Related]
38. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663 [TBL] [Abstract][Full Text] [Related]
39. Recent efforts in the development of a sporozoite vaccine against human malaria. Hockmeyer WT; Dame JB Adv Exp Med Biol; 1985; 185():233-45. PubMed ID: 3907309 [TBL] [Abstract][Full Text] [Related]
40. A robust neutralization test for Plasmodium falciparum malaria. Saul A; Miller LH J Exp Med; 2001 Jun; 193(12):F51-4. PubMed ID: 11413200 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]